[Treatment of acute myeloid leukemia].
D000328:Adult; D000609:Aminoacridines / Q000008:administration & dosage; D000677:Amsacrine; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D013866:Thioguanine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000609:Aminoacridines; D003692:Delayed-Action Preparations; D000677:Amsacrine; D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D013866:Thioguanine; D011241:Prednisone; D003630:Daunorubicin
Die Behandlung der akuten myeloischen Leukämie.